Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-24

FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for hydroxyzine pamoate submitted by Sandoz Inc (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyzine pamoate (Hydroxyzine pamoate)

Snippet

SUPPL AP for HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE)